CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge

CCL19 Immunogen
DOI: 10.1128/msphere.00058-21 Publication Date: 2021-06-03T15:44:11Z
ABSTRACT
An effective HSV-2 vaccine should induce antigen (Ag)-specific immune responses against viral mucosal infection. This study reveals that chemokine CCL19 or CCL28 enhanced glycoprotein D ectodomain (gD-306aa)-induced vaginal virus challenge.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (9)